FDA
The new article describes in detail the applicability scope and also outlines specific considerations for certain groups of patients that require special attention in order to ensure they are properly represented among study participants.
FDA
The article outlines the key points of the approach to be used in order to improve participation in clinical studies conducted in the US.
FDA
The article describes in brief the key points related to the regulatory framework for laboratory-developed tests.
FDA
The new article describes in detail the applicability scope of the new regulatory policy for laboratory-developed tests.
FDA
The article provides a brief overview of the regulatory approach to be applied with respect to certain tests intended to be used in the context of an emergency.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
